MLM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Martin Marietta Materials Inc (MLM) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock's recent asset exchange with QUIKRETE, expected revenue growth, and infrastructure exposure make it a strong candidate for long-term growth, despite mixed Q4 results. Analysts remain optimistic, with several maintaining Buy or Overweight ratings and increasing price targets. Current technical indicators and options data suggest a neutral to slightly bullish sentiment, supporting the buy decision.
The stock's moving averages are bullish (SMA_5 > SMA_20 > SMA_200), indicating a positive long-term trend. However, the MACD is negatively expanding (-0.635), and RSI is neutral (50.561), suggesting no immediate momentum. Key support is at 654.282, and resistance is at 696.287, with the current pre-market price of 678.51 sitting above the pivot point of 675.284.
Completion of QUIKRETE asset exchange, adding significant operational capacity and cash.
Updated 2026 guidance projects 12% growth in aggregate volume and strong revenue/EBITDA growth.
Analysts' optimism with raised price targets and Buy/Overweight ratings.
Exposure to infrastructure growth and potential federal spending acceleration.
Mixed Q4 results with revenue below expectations and a decline in net income and EPS.
Initial FY2026 guidance was lower than Street expectations, causing some analyst downgrades.
MACD and RSI indicate no clear short-term momentum.
In Q4 2025, revenue increased by 8.57% YoY to $1.534 billion, but net income dropped by 5.10% YoY to $233 million. EPS also declined by 3.56% YoY to 4.6. Gross margin improved slightly to 30.46%, up 1.20% YoY. The company's financials show mixed performance, with revenue growth but declining profitability.
Analysts are generally positive on MLM, with several firms raising price targets post-Q4. Morgan Stanley increased the target to $706, Citi to $780, and Truist to $710, maintaining Buy/Overweight ratings. However, Stephens, RBC Capital, and DA Davidson lowered price targets due to Q4 earnings misses and conservative guidance. The consensus reflects optimism for long-term growth but acknowledges short-term challenges.
